United States · Investor

BioGenerator

Last cheque observed Sep 2026; 35 cheques on record.

Deploying nowVenture studio

SeedSeries AHealthAgricultureTherapeutics

Deploying now
100%of best year2cheques in 12 months, 35 on record
Since the last cheque55days00hrs00min00sec
Median round$2.4MRounds led1 of 35Sole investor16 roundsMostly inUnited States, 100%
Pitch BioGenerator

BioGenerator highlights

  1. 01

    2 cheques in the last 12 months

  2. 02

    Mostly Seed and Series A: 63% of its rounds

  3. 03

    Sole investor in 16 rounds, median $300K

What they do

BioGenerator Ventures creates, builds, and invests in companies that are solving important problems in human health and agriculture.From their own website
Type
Venture studio
Cheque size
Not stated
Stages
SeedSeries A
Sectors
HealthAgricultureTherapeutics
Based in
St. Louis, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first35 appearances

  1. 2026

    2 rounds

  2. Sept
    Spearhead BioSeed · US · AgFunderNews$1.6MLed
  3. Jul
    Allotera TherapeuticsSeries C · US · Firms' own news pages$35MWith 4 others
  4. 2018

    1 round

  5. May
    CanopySeries A · US · FinSMEs$2.4MWith 4 others
  6. 2015

    7 rounds

  7. Sept
    MedSocketSeed · US$300KWith 2 others
  8. Jul
    Confluence Life SciencesSeries B · US$2.4MWith 4 others
  9. Jun
    NeuroLutionsVenture · US$1.1MWith 2 others
  10. May
    ArvegenixSeries A · US$2.5MWith 3 others
  11. Apr
    Euclises PharmaceuticalsSeries A · US$700KWith 2 others
  12. Mar
    CardiaLenSeries B · US$1.5MWith 6 others
  13. Mar
    ApseSeed · US$350KSole investor
  14. 2014

    4 rounds

  15. Nov
    KyphaVenture · US$3.5MWith 2 others
  16. Sept
    Euclises PharmaceuticalsSeries A · US$1.3MWith 4 others
  17. Sept
    ImmunoPhotonicsSeries A · US$1.8MWith 2 others
  18. Feb
    MedSocketSeed · US$50KWith 1 other
  19. 2013

    7 rounds

  20. May
    GraematterSeed · US · bizjournals.com$835KWith 2 others
  21. May
    BacterioscanVenture · US · bizjournals.com$2.1MWith 2 others
  22. May
    GeneriCoDebt · US · sec.gov$435KSole investor
  23. Apr
    Adarza BioSystemsUS · pevc.dowjones.comUndisclosedWith 1 other
  24. Apr
    Antegrin TherapeuticsSeed · US · bizjournals.comUndisclosedSole investor
  25. Feb
    Tansna TherapeuticsSeed · US · bizjournals.comUndisclosedSole investor
  26. Jan
    Benson Hill BiosystemsDebt · US · sec.gov$300KSole investor
  27. 2012

    8 rounds

  28. Sept
    Confluence Life SciencesSeries A · US · finsmes.com$4.0MWith 2 others
  29. Apr
    Pulse TherapeuticsSeries B · US · onbiovc.com$3.1MWith 1 other
  30. Jan
    KyphaVenture · US · sec.gov$206KWith 1 other
  31. Jan
    Companion PharmaSeed · US · biogenerator.orgUndisclosedSole investor
  32. Jan
    ApseSeed · USUndisclosedSole investor
  33. Jan
    ApseGrant · US · cdn.harmonyapp.comUndisclosedSole investor
  34. Jan
    Array BridgeGrant · US · biogenerator.orgUndisclosedSole investor
  35. Jan
    ARTA BioscienceGrant · US · biogenerator.orgUndisclosedSole investor
  36. 2011

    4 rounds

  37. Feb
    Mobius TherapeuticsUS · marketwire.comUndisclosedSole investor
  38. Jan
    Array BridgeSeed · US · biogenerator.orgUndisclosedSole investor
  39. Jan
    Apertus PharmaceuticalsGrant · US · cdn.harmonyapp.comUndisclosedSole investor
  40. Jan
    Confluence Discovery TechnologiesSeed · US · biogenerator.org$75KSole investor
  41. 2008

    1 round

  42. Jul
    PixelEXX SystemsSeed · US$250KSole investor
  43. 2005

    1 round

  44. Jan
    APT TherapeuticsSeed · US · biogenerator.orgUndisclosedSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 25 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as BioGenerator. A count of rooms they were both in, not a relationship either has claimed.

St. Louis Arch AngelsAngel network7rounds togetherCultivation CapitalVC firm5rounds togetherMissouri Technology CorporationGovernment5rounds togetherCapital InnovatorsAccelerator2rounds togetherHelix FundVC firm2rounds togetherMercury FundVC firm2rounds together

Recently backed

The latest companies BioGenerator put money into.

Spearhead Bio$1.6M · Sept 2026Allotera Therapeutics$35M · Jul 2026

Quick answers about BioGenerator

What does BioGenerator invest in?

BioGenerator invests most often at Seed and Series A (63% of the rounds on record), in sectors such as Health, Agriculture and Therapeutics.

How active is BioGenerator?

35 investments on record, 2 of them in the last 12 months, and it led 1. The most recent was in Sept 2026.

What has BioGenerator invested in recently?

Its most recent investments on record: Spearhead Bio (Seed, Sept 2026), Allotera Therapeutics (Series C, Jul 2026) and Canopy (Series A, May 2018).

How big are BioGenerator's cheques?

The median round it joins is $2.4M.

Does BioGenerator lead rounds?

Sometimes: it led 1 of its 35 investments on record (3%).

Where does BioGenerator invest?

Most of the companies it backs are in the United States (100%).

Is BioGenerator investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

Who does BioGenerator invest alongside?

Most often St. Louis Arch Angels (7 rounds together), Cultivation Capital (5 rounds together) and Missouri Technology Corporation (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it